>
Merck KGaA logo

MRK - Merck KGaA Share Price

€142.75 1.5  1.0%

Last Trade - 4:35pm

Sector
Healthcare
Size
Large Cap
Market Cap £53.38bn
Enterprise Value £62.96bn
Revenue £15.23bn
Position in Universe 21st / 1051
Bullish
Bearish
Unlock MRK Revenue
Momentum
Relative Strength (%)
1m -5.05%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.86%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
12,845 15,024 14,517 14,836 16,152 17,534 18,554 19,702 +6.4%
+9.7 +16.0 +61.4 -48.5 +19.6 +29.5 +47.2 +10.4
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MerckKGaA revenues increased 9% to EUR17.53B. Net incomeapplicable to common stockholders excluding extraordinaryitems increased 54% to EUR1.99B. Revenues reflectPerformance Materials segment increase of 31% to EUR3.38B,Life Science segment increase of 9% to EUR7.52B, UnitedStates (Country) segment increase of 13% to EUR4.64B,Adjustment segment increase of 15% to EUR3.74B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MRK
Graphical History

Revenue

MRK Revenue Unlock MRK Revenue

Net Income

MRK Net Income Unlock MRK Revenue

Normalised EPS

MRK Normalised EPS Unlock MRK Revenue

PE Ratio Range

MRK PE Ratio Range Unlock MRK Revenue

Dividend Yield Range

MRK Dividend Yield Range Unlock MRK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MRK EPS Forecasts Unlock MRK Revenue
Profile Summary

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since October 20, 1995
No. of Shareholders: n/a
No. of Employees: 58,096
Sector Healthcare
Industry Pharmaceuticals
Index FTSEurofirst 300 Pharmaceuticals & Biotechnology , FTSEurofirst 300 , FTSEurofirst 300 Eurozone , FTSEurofirst 300 Ex UK, Xetra DAX , Xetra Prime All Share ,
Exchange XETRA
Shares in Issue 434,777,878
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MRK Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MRK
Upcoming Events for MRK
Wednesday 12th May, 2021
Q1 2021 Merck KGaA Earnings Release
Wednesday 12th May, 2021
Q1 2021 Merck KGaA Earnings Press Conference
Wednesday 12th May, 2021
Q1 2021 Merck KGaA Earnings Call
Thursday 5th August, 2021
Half Year 2021 Merck KGaA Earnings Release
Thursday 5th August, 2021
Half Year 2021 Merck KGaA Earnings Press Conference
Thursday 5th August, 2021
Half Year 2021 Merck KGaA Earnings Press Conference
Thursday 5th August, 2021
Half Year 2021 Merck KGaA Earnings Call
Frequently Asked Questions for Merck KGaA
What is the Merck KGaA share price?

As of 4:35pm, shares in Merck KGaA are trading at €142.75, giving the company a market capitalisation of £53.38bn. This share price information is delayed by 15 minutes.

How has the Merck KGaA share price performed this year?

Shares in Merck KGaA are currently trading at €142.75 and the price has moved by 31.93% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Merck KGaA price has moved by 2.54% over the past year.

What are the analyst and broker recommendations for Merck KGaA?

Of the analysts with advisory recommendations for Merck KGaA, there are there are currently 6 "buy" , 10 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Merck KGaA is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Merck KGaA next release its financial results?

Merck KGaA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Merck KGaA dividend yield?

The Merck KGaA dividend yield is 0.99% based on the trailing twelve month period.

Does Merck KGaA pay a dividend?

Last year, Merck KGaA paid a total dividend of 1.4, and it currently has a trailing dividend yield of 0.99%. Looking ahead, Merck KGaA has not announced an ex-dividend date yet.

When does Merck KGaA next pay dividends?

Merck KGaA has yet to annouce their ex-dividend date. The historic dividend yield on Merck KGaA shares is currently 0.99%.

How do I buy Merck KGaA shares?

To buy shares in Merck KGaA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Merck KGaA?

Shares in Merck KGaA are currently trading at €142.75, giving the company a market capitalisation of £53.38bn.

Where are Merck KGaA shares listed? Where are Merck KGaA shares listed?

Here are the trading details for Merck KGaA:

Country of listing: Germany
Exchange: GER
Ticker Symbol: MRK
What kind of share is Merck KGaA?

Based on an overall assessment of its quality, value and momentum, Merck KGaA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Merck KGaA share price forecast 2021?

Shares in Merck KGaA are currently priced at €142.75. At that level they are trading at 3.9% discount to the analyst consensus target price of 0.00.

Analysts covering Merck KGaA currently have a consensus Earnings Per Share (EPS) forecast of 6.946 for the next financial year.

How can I tell whether the Merck KGaA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Merck KGaA. Over the past six months, the relative strength of its shares against the market has been -10.16%. At the current price of €142.75, shares in Merck KGaA are trading at 6.59% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Merck KGaA PE Ratio?

The Merck KGaA PE ratio based on its reported earnings over the past 12 months is 29.95. The shares are currently trading at €142.75.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Merck KGaA?

Merck KGaA's management team is headed by:

Wolfgang Buechele - CSU
Kai Beckmann - CEX
Constantin Fest - DIR
Marcus Kuhnert - CFO
Belen Garijo - CMG
Helga Ruebsamen-Schaeff - IND
Sascha Held - VSU
Renate Koehler - IND
Peter Merck - IND
Daniel Thelen - IND
Simon Thelen - IND
Peter Guenter - EXB
Who are the major shareholders of Merck KGaA?

Here are the top five shareholders of Merck KGaA based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 7.4% (9.57m shares)
DWS Investment GmbH Investment Advisor/Hedge Fund
Percentage owned: 3.97% (5.13m shares)
Amundi Asset Management Investment Advisor/Hedge Fund
Percentage owned: 2.99% (3.86m shares)
Templeton Investment Counsel, L.L.C. Investment Advisor/Hedge Fund
Percentage owned: 2.98% (3.85m shares)
Select Equity Group, L.P. Investment Advisor/Hedge Fund
Percentage owned: 2.97% (3.83m shares)
Similar to MRK
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.